Interchange Capital Partners LLC lowered its position in Tempus AI, Inc. (NASDAQ:TEM – Free Report) by 90.3% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 650 shares of the company’s stock after selling 6,042 shares during the period. Interchange Capital Partners LLC’s holdings in Tempus AI were worth $41,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in TEM. Vanguard Group Inc. increased its holdings in Tempus AI by 6,247.5% during the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock worth $289,204,000 after buying an additional 5,900,668 shares during the last quarter. ARK Investment Management LLC boosted its position in Tempus AI by 35.9% during the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock worth $361,867,000 after purchasing an additional 1,981,755 shares during the period. Nikko Asset Management Americas Inc. boosted its position in Tempus AI by 31.5% during the first quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock worth $205,401,000 after purchasing an additional 1,021,460 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Tempus AI by 31.4% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock valued at $205,284,000 after acquiring an additional 1,016,384 shares during the period. Finally, CloudAlpha Capital Management Limited Hong Kong bought a new position in shares of Tempus AI in the first quarter valued at approximately $34,119,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on the stock. Morgan Stanley lifted their target price on shares of Tempus AI from $65.00 to $68.00 and gave the company an “overweight” rating in a research report on Tuesday, August 12th. HC Wainwright lifted their price target on shares of Tempus AI from $90.00 to $98.00 and gave the stock a “buy” rating in a research note on Friday, September 12th. Needham & Company LLC reissued a “buy” rating and set a $70.00 price target on shares of Tempus AI in a research note on Friday, August 8th. Guggenheim lifted their price target on shares of Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, September 26th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a research note on Wednesday, October 8th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Tempus AI currently has an average rating of “Hold” and a consensus target price of $71.83.
Insider Buying and Selling
In related news, CFO James William Rogers sold 7,528 shares of Tempus AI stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $561,965.20. Following the sale, the chief financial officer owned 138,473 shares in the company, valued at $10,337,009.45. The trade was a 5.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Theodore Leonsis sold 44,000 shares of Tempus AI stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $69.90, for a total transaction of $3,075,600.00. Following the completion of the sale, the director owned 86,756 shares in the company, valued at approximately $6,064,244.40. This trade represents a 33.65% decrease in their position. The disclosure for this sale can be found here. Insiders sold 933,662 shares of company stock valued at $68,070,993 over the last quarter. Company insiders own 26.27% of the company’s stock.
Tempus AI Stock Up 2.3%
Shares of NASDAQ TEM opened at $91.91 on Thursday. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. Tempus AI, Inc. has a 52 week low of $31.36 and a 52 week high of $104.32. The firm’s fifty day moving average is $81.00 and its 200 day moving average is $65.55. The company has a market cap of $15.97 billion, a price-to-earnings ratio of -77.24 and a beta of 4.87.
Tempus AI (NASDAQ:TEM – Get Free Report) last issued its earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The company had revenue of $314.64 million for the quarter, compared to the consensus estimate of $296.84 million. During the same period in the previous year, the firm earned ($6.86) earnings per share. The firm’s revenue for the quarter was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. On average, equities research analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current year.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More
- Five stocks we like better than Tempus AI
- How to invest in marijuana stocks in 7 steps
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- 5 Top Rated Dividend Stocks to Consider
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Best Stocks Under $5.00
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM – Free Report).
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.